Project 171040
Molecular Examination of Thymocyte Negative Selection in vivo
Molecular Examination of Thymocyte Negative Selection in vivo
Project Information
| Study Type: | Other Mechanistic_Study |
| Therapeutic Area: | Immunology |
| Research Theme: | Biomedical |
| Disease Area: | autoimmune diseases (diabetes, multiple sclerosis, rheumatoid arthritis) |
| Data Type: | Canadian |
Institution & Funding
| Principal Investigator(s): | Baldwin, Troy A |
| Institution: | University of Alberta |
| CIHR Institute: | Infection and Immunity |
| Program: | |
| Peer Review Committee: | New Investigators A |
| Competition Year: | 2008 |
| Term: | 5 yrs 0 mth |
Abstract Summary
T cells are a type of white blood cell that are critical for providing protection against infections and cancer. T cells mature in an organ called the thymus. It is in the thymus where the ability of T cells to discriminate between self and foreign molecules is established. In particular, T cells capable of recognizing foreign molecules are allowed to leave the thymus and enter the circulation, while T cells that recognize self-molecules are eliminated. In humans and mice, it has recently been demonstrated that in cases where self-reactive T cells are not eliminated in the thymus, autoimmune diseases such as diabetes, multiple sclerosis and rheumatoid arthritis may develop. My work seeks to understand how self-reactive T cells are eliminated in the thymus using a mouse model system that accurately reflects this physiological process. This information will greatly increase our knowledge of how autoimmune diseases begin and may provide a means to prevent autoimmune disease in susceptible individuals.
Research Characteristics
This project includes the following research characteristics:
Study Justification
"My work seeks to understand how self-reactive T cells are eliminated in the thymus using a mouse model system that accurately reflects this physiological process."
Novelty Statement
"This information will greatly increase our knowledge of how autoimmune diseases begin and may provide a means to prevent autoimmune disease in susceptible individuals."
Methodology Innovation
using a mouse model to study the in vivo mechanisms of thymocyte negative selection